Menu
If you have been diagnosed with depression, are currently experiencing symptoms, sometimes referred to as a depressive episode, and are between the ages of 18–65 years, you may be eligible to participate. This investigational drug is administered orally, once daily.
This study is for people who are currently taking antidepressants but find that they are not fully managing their symptoms. If you are taking an antidepressant and are eligible for this study, you will continue with your current antidepressant in addition to taking the investigational drug.
People who enroll in the study will be randomly assigned (like the flip of a coin) to a study treatment group to take either the investigational drug or a placebo. There is an equal chance (50/50) of being assigned to either group. Neither you nor the study doctor will know whether you are assigned to the investigational or placebo group. Those who qualify and meet all other eligibility criteria will be trained in the use of the investigational drug. Participants may be compensated for time and travel.
The Reliance study may last up to ten weeks. This time includes a screening period, a treatment period, and a follow-up period. You can stop your participation in the study at any time.
To help others by expanding what we know about depression and its treatment
You may gain additional resources for managing your depression
We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
For more detailed information on the cookies we use, please check our Privacy Policy.
By continuing to access this website, you are giving us consent to collect cookies.
